Seeking Investors for NYC Medspa Acquisition at 2.8x EBITDA

I've got a high-end New York Medspa signed to a LOI. $4.3 million purchase price with $1.5 million in EBITDA = 2.8x. Seeking $4 million in a combination of debt (3x DSCR) and convertible preferred. Targeted IRR 35% +. This will be the acquisition for a roll-up of 3-5 Medspas in the next 2 years. Even higher IRR is possible with branding, influencers, social media marketing and a sale of the roll-up entities at 5x. Alan Donenfeld --@----.com###-###-####